» Articles » PMID: 26238001

Incorrect Diagnosis of Clostridium Difficile Infection in a University Hospital in Japan

Overview
Publisher Elsevier
Date 2015 Aug 5
PMID 26238001
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Physicians often fail to suspect Clostridium difficile infection (CDI) and many microbiology laboratories use suboptimal diagnostic techniques. To estimate the extent of and reasons for incorrect diagnosis of CDI in Japan, we investigated toxigenic C. difficile isolated from all stool culture samples and clinical course. Over a 12-month period in 2010, all stool culture samples (n = 975) submitted from inpatients in a university hospital in Japan were cultured for C. difficile and routine microbiological testing was conducted. In total, 177 C. difficile isolates were recovered, and 127 isolates were toxigenic. Among the toxin-A-positive/toxin-B-positive isolates, 12 were also positive for the binary toxin gene. However, clinically important ribotypes, such as 027 and 078, were not identified. A total of 58 (45.7%) cases with toxigenic C. difficile had unformed stool, and the incidence CDI was 1.6 cases per 10,000 patient-days. Of these 58 cases, 40 were not diagnosed in routine testing due to a lack of clinical suspicion (24.1%, 14/58) or a negative C. difficile toxin assay result (44.8%, 26/58). A stool toxin assay was performed in 54 patients (78.2%, 54/69) who did not have unformed stool. The present study demonstrated that a significant number of CDI cases in Japan might be overlooked or misdiagnosed in clinical practice due to a lack of clinical suspicion and limitations of microbiological testing for CDI in Japan. Providing education to promote awareness of CDI among physicians is important to improve the accuracy of diagnosis in Japan.

Citing Articles

Regional and temporal genotype profiling of Clostridioides difficile in a multi-institutional study in Japan.

Sagisaka Y, Ishibashi M, Hosokawa D, Nakagawa H, Yonogi S, Minami K Sci Rep. 2024; 14(1):21559.

PMID: 39284883 PMC: 11405520. DOI: 10.1038/s41598-024-72252-y.


Implementation of multifaceted diagnostic stewardship for infection during the COVID-19 pandemic at a small Japanese hospital.

Sasaki Y, Yano M, Umehara A, Tagashira Y Antimicrob Steward Healthc Epidemiol. 2024; 4(1):e96.

PMID: 38836045 PMC: 11149025. DOI: 10.1017/ash.2024.93.


Budget Impact Analysis of Adopting a One-Step Nucleic Acid Amplification Testing (NAAT) Alone Diagnostic Pathway for in Japan Compared to a Two-Step Algorithm with Glutamate Dehydrogenase/Toxin Followed by NAAT.

Lim V, Tomaru T, Chua B, Ma Y, Yanagihara K Diagnostics (Basel). 2023; 13(8).

PMID: 37189564 PMC: 10137341. DOI: 10.3390/diagnostics13081463.


Genomic characterization of nine Clostridioides difficile strains isolated from Korean patients with Clostridioides difficile infection.

Ahn S, Lee S, Kim U, Jang H, Choi H, Choy H Gut Pathog. 2021; 13(1):55.

PMID: 34530913 PMC: 8447795. DOI: 10.1186/s13099-021-00451-3.


Community-acquired fulminant Clostridioides (Clostridium) difficile infection by ribotype 027 isolate in Japan: a case report.

Hiraki M, Suzuki R, Tanaka N, Fukunaga H, Kinoshita Y, Kimura H Surg Case Rep. 2021; 7(1):137.

PMID: 34101061 PMC: 8187545. DOI: 10.1186/s40792-021-01220-9.